Envision Pharma Group

Envision Pharma Group is a scientific communications and technology company specializing in the life sciences sector. It provides comprehensive services in medical publication planning, execution, and consultancy, aiming to enhance evidence-based communication in a compliant and transparent manner. The company collaborates with clients, authors, and the medical publishing community to develop effective communication programs. Envision Pharma Group also offers software solutions designed for pharmaceutical, biotechnology, and medical device companies, facilitating the formation of global medical strategies and aiding cross-functional teams in their communication efforts. Their services include publication planning, regulatory writing, and public relations, enabling clients to manage scientific communications effectively while adhering to regulatory standards. The organization prides itself on flexibility, adapting to client needs in team composition, payment models, and project timelines.

Greg Carpenter

Chief of Staff, CEO and member of the Executive Leadership Team

6 past transactions

doDOC

Acquisition in 2021
doDOC Corp. operates a cloud-based writing platform that enhances document preparation and compliance processes for various users, including academic institutions, pharmaceutical companies, and environmental consultants. Founded in 2014 and based in Boston, the platform facilitates the drafting of scientific articles, reports, essays, and theses, allowing users to format documents with a single click. It supports real-time collaboration, enabling multiple users to simultaneously work on the same document while maintaining strict control over permissions and an audit trail for accountability. The platform also simplifies the importation of existing documents, automatic citation management, and the inclusion of images and tables. By streamlining the writing and management experience, doDOC significantly accelerates report generation and improves overall productivity, making it suitable for a range of organizations from startups to large enterprises.

Two Labs

Acquisition in 2020
Two Labs is a pharmaceutical service company that specializes in providing consultancy services to the pharmaceutical and biotechnology sectors. The firm offers a range of services, including strategic consulting, market access, market intelligence, and integrated pharmaceutical services. These offerings assist clients in navigating various stages of the product lifecycle, from commercialization to lifecycle management and acquisition transition. By focusing on removing barriers throughout the product lifecycle, Two Labs aims to enhance the effectiveness of its clients' strategies and implementations.

90 Ten

Acquisition in 2020
90TEN is an independent healthcare communications consultancy.

Touch Creative Design

Acquisition in 2017
Touch Creative Design is a Pharma/Healthcare focused agency with multi-industry experience – predominantly healthcare focused they also work across other industries. This experience keeps their ideas fresh, allowing them to evaluate and experiment with the latest technologies and learn what works with respect to customer engagement. Specialties include: Creative strategy development; Digital & technology-based experiences; Exhibitions and Event services; Branding and traditional creative media.

Alligent Group

Acquisition in 2015
Alligent Group is a medical affairs consulting agency based in Stirling, New Jersey, that specializes in providing integrated medical communication solutions for the biopharmaceutical industry. Founded in 2009 and operating as a subsidiary of Envision Pharma, Inc., Alligent offers a comprehensive range of services including medical strategy development, clinical trial design, stakeholder engagement, and publication strategy. The agency supports clients with impact analytics, competitive assessments, content development, and training for internal stakeholders. Its expertise extends to thought leader engagement, market intelligence, and social media analysis, ensuring that clients receive timely and relevant data to inform their medical affairs initiatives. Alligent is committed to delivering effective solutions that align with the specific needs of its clients in the biopharmaceutical sector.

ProScribe

Acquisition in 2014
ProScribe is a company that was acquired by Envision Pharma Group in 2014.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.